These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11816336)

  • 1. [Third generation oral contraceptives and risk of venous thrombosis].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(3):346. PubMed ID: 11816336
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 3. [Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2004 Jun; 124(11):1521-2. PubMed ID: 15195157
    [No Abstract]   [Full Text] [Related]  

  • 4. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
    [No Abstract]   [Full Text] [Related]  

  • 5. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.
    Kemmeren JM; Algra A; Grobbee DE
    BMJ; 2001 Jul; 323(7305):131-4. PubMed ID: 11463678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sexual abstinence of thrombosis? Comment on the controversy regarding the "pill of the 3rd generation"].
    Strobel E
    Fortschr Med; 1995 Nov; 113(33):18, 20. PubMed ID: 8575701
    [No Abstract]   [Full Text] [Related]  

  • 7. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?
    Sapp AV; Lindbloom EJ
    J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
    Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract]   [Full Text] [Related]  

  • 9. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components.
    Jick SS; Myers MW; Jick H
    Lancet; 1999 Jul; 354(9175):302-3. PubMed ID: 10440310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Third generation oral contraceptives and risk of venous thrombosis--the English lesson].
    Sørensen MB
    Ugeskr Laeger; 2002 Apr; 164(18):2418; author reply 2418-9. PubMed ID: 12024851
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral venous thrombosis as a complication of oral contraceptive use in a 15-year-old patient: a case report.
    Hill LW; Hindelang FM
    J La State Med Soc; 2007; 159(4):195, 197. PubMed ID: 17987956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third generation oral contraceptives.
    Skegg DC
    BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives.
    Med Lett Drugs Ther; 2000 May; 42(1078):42-4. PubMed ID: 10847115
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of venous thromboembolism with third-generation oral contraceptives: A review.
    Weiss G
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 2):295-301. PubMed ID: 9988833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Poulter NR; Chang CL; Farley TM; Marmot MG; Meirik O
    Lancet; 1999 Jul; 354(9175):301-2. PubMed ID: 10440309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal contraception with gestagens].
    Petersen KR; Poulsen EF
    Ugeskr Laeger; 2001 Aug; 163(34):4553-6. PubMed ID: 11530558
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sale of oral contraceptives, births and abortions prior to and after the "Marvelon issue"].
    Skjeldestad FE
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):339-44. PubMed ID: 10827525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and metabolic effects of oral contraceptives].
    Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
    Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.